Vimarsana
Biggest News Aggregation in the World

Rogerj Packer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rogerj Packer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rogerj Packer Today - Breaking & Trending Today

Your Daily Phil: IFCJ distributes food aid ahead of Passover - Vimarsana News

Your Daily Phil: IFCJ distributes food aid ahead of Passover

Good Friday morning. For less-distracted reading over the weekend, browse this week’s edition of The Weekly Print, a curated print-friendly PDF featuring a selection of recenteJewishPhilanthropy and Jewish Insider stories, including: At antisemitism-focused Ruderman conference, rabbi whose son was killed on Oct. 7 focuses instead on...

To save a life: Lessons for launching a medical R&D initiative - Vimarsana News

To save a life: Lessons for launching a medical R&D initiative

On Nov. 7, 2015, my family received the devastating news that our 9-year-old son Frederico was diagnosed with medulloblastoma, a pediatric brain tumor. At that shattering moment, I made two commitments: one to Frederico, a promise to dedicate my life...

Clinical Challenges: Cognitive and Psychosocial Support in Neurofibromatosis - Vimarsana News

Clinical Challenges: Cognitive and Psychosocial Support in Neurofibromatosis

Personalized management for patient-specific needs is crucial

Clinical Challenges: New Hope in Management of Neurofibromatosis - Vimarsana News

Clinical Challenges: New Hope in Management of Neurofibromatosis

Group of genetic disorders cause tumors along nerves, causing pain and a range of complications

FDA approves first systemic therapy for children with BRAF V600E-mutated low-grade glioma - Vimarsana News

FDA approves first systemic therapy for children with BRAF V600E-mutated low-grade glioma

The FDA approved dabrafenib with trametinib for children with previously untreated low-grade glioma who harbor BRAF V600E mutations and require systemic therapy.The approval — which applies to children aged 1 year or older — is the first for a systemic therapy for first-line treatment of this patient population.

Source: healio.com